186 related articles for article (PubMed ID: 23823925)
1. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity.
Tsakova AD; Gateva AT; Kamenov ZA
Int J Vitam Nutr Res; 2012 Dec; 82(6):399-404. PubMed ID: 23823925
[TBL] [Abstract][Full Text] [Related]
2. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
3. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
[TBL] [Abstract][Full Text] [Related]
4. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome.
Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M
Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832
[TBL] [Abstract][Full Text] [Related]
5. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
8. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
9. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.
Mahmoudi T; Gourabi H; Ashrafi M; Yazdi RS; Ezabadi Z
Fertil Steril; 2010 Mar; 93(4):1208-14. PubMed ID: 19230880
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
Velija-Ašimi Z
Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
[TBL] [Abstract][Full Text] [Related]
11. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.
Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E
Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
13. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
Kozakowski J; Kapuścińska R; Zgliczyński W
Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.
Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I
Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314
[TBL] [Abstract][Full Text] [Related]
15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Yavuz DG
J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
